Nuveen, LLC Akero Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 308,326 shares of AKRO stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
308,326Holding current value
$13.9 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
231Shares Held
69.3MCall Options Held
363KPut Options Held
688K-
Rtw Investments, LP New York, NY6.86MShares$308 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$271 Million0.09% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$267 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$251 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$235 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...